Doppler W - Search Results

1

Gamma-interferon reduces expression of the protooncogene c-erbB-2 in human ovarian carcinoma cells.

Marth C, Müller-Holzner E, Greiter E, Cronauer MV, Zeimet AG, Doppler W, Eibl B, Hynes NE, Daxenbichler G. Marth C, et al. Among authors: doppler w. Cancer Res. 1990 Nov 1;50(21):7037-41. Cancer Res. 1990. PMID: 2119884

2

Interferon-gamma expression is an independent prognostic factor in ovarian cancer.

Marth C, Fiegl H, Zeimet AG, Müller-Holzner E, Deibl M, Doppler W, Daxenbichler G. Marth C, et al. Among authors: doppler w. Am J Obstet Gynecol. 2004 Nov;191(5):1598-605. doi: 10.1016/j.ajog.2004.05.007. Am J Obstet Gynecol. 2004. PMID: 15547530

3

Retinoic acid modulates prolactin receptor expression and prolactin-induced STAT-5 activation in breast cancer cells in vitro.

Widschwendter M, Widschwendter A, Welte T, Daxenbichler G, Zeimet AG, Bergant A, Berger J, Peyrat JP, Michel S, Doppler W, Marth C. Widschwendter M, et al. Among authors: doppler w. Br J Cancer. 1999 Jan;79(2):204-10. doi: 10.1038/sj.bjc.6690034. Br J Cancer. 1999. PMID: 9888458 Free PMC article.

4

[Interferon-gamma suppresses expression of the HER-2 oncogene in ovarian cancer cells].

Marth C, Müller-Holzner E, Zeimet AG, Greiter E, Cronauer MV, Doppler W, Eibl B, Hynes NE, Daxenbichler G. Marth C, et al. Among authors: doppler w. Gynakol Geburtshilfliche Rundsch. 1992;32(1):31-4. doi: 10.1159/000271830. Gynakol Geburtshilfliche Rundsch. 1992. PMID: 1355379 German.

5

Epidermal growth factor reduces HER-2 protein level in human ovarian carcinoma cells.

Marth C, Lang T, Cronauer MV, Doppler W, Zeimet AG, Bachmair F, Ullrich A, Daxenbichler G. Marth C, et al. Among authors: doppler w. Int J Cancer. 1992 Sep 9;52(2):311-6. doi: 10.1002/ijc.2910520226. Int J Cancer. 1992. PMID: 1355758

6

Effects of interferons on the expression of the proto-oncogene HER-2 in human ovarian carcinoma cells.

Marth C, Cronauer MV, Doppler W, Ofner D, Ullrich A, Daxenbichler G. Marth C, et al. Among authors: doppler w. Int J Cancer. 1992 Jan 2;50(1):64-8. doi: 10.1002/ijc.2910500114. Int J Cancer. 1992. PMID: 1370227

7

Prognostic significance of signal transducer and activator of transcription 1 activation in breast cancer.

Widschwendter A, Tonko-Geymayer S, Welte T, Daxenbichler G, Marth C, Doppler W. Widschwendter A, et al. Among authors: doppler w. Clin Cancer Res. 2002 Oct;8(10):3065-74. Clin Cancer Res. 2002. PMID: 12374673

8

Favorable prognostic value of SOCS2 and IGF-I in breast cancer.

Haffner MC, Petridou B, Peyrat JP, Révillion F, Müller-Holzner E, Daxenbichler G, Marth C, Doppler W. Haffner MC, et al. Among authors: doppler w. BMC Cancer. 2007 Jul 25;7:136. doi: 10.1186/1471-2407-7-136. BMC Cancer. 2007. PMID: 17651480 Free PMC article.

9

Infiltrating CD11b+CD11c+ cells have the potential to mediate inducible nitric oxide synthase-dependent cell death in mammary carcinomas of HER-2/neu transgenic mice.

Parajuli N, Müller-Holzner E, Böck G, Werner ER, Villunger A, Doppler W. Parajuli N, et al. Among authors: doppler w. Int J Cancer. 2010 Feb 15;126(4):896-908. doi: 10.1002/ijc.24805. Int J Cancer. 2010. PMID: 19653277

10

Toll-like receptor 9 expression in breast and ovarian cancer is associated with poorly differentiated tumors.

Berger R, Fiegl H, Goebel G, Obexer P, Ausserlechner M, Doppler W, Hauser-Kronberger C, Reitsamer R, Egle D, Reimer D, Müller-Holzner E, Jones A, Widschwendter M. Berger R, et al. Among authors: doppler w. Cancer Sci. 2010 Apr;101(4):1059-66. doi: 10.1111/j.1349-7006.2010.01491.x. Epub 2010 Jan 12. Cancer Sci. 2010. PMID: 20156214 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters